Daewoong to patent pravastatin composite for prolonged efficacy.
Published: 2005-09-29 07:00:00
Updated: 2005-09-29 07:00:00
Daewoong announced that a composite of sodium pravastatin with co-polyvidon was patent registered for the improvement of its stability and thereby prolonged efficacy characterized in which co-polividon protect pravastatin from hydration.
Daewoong said that the pilot product test already comple...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
